Assignee profile:

HELIXMITH CO., LTD.

City:

Seoul

Country:

South Korea

Published Applications:

13

Last publication date:

2022-11-17

Patent Grants:

13

Last grant date:

2026-03-10

Top Inventors for applications by HELIXMITH CO., LTD.

These are the the leading inventors for applications assigned to HELIXMITH CO., LTD.:

Recent patent applications by HELIXMITH CO., LTD.

HELIXMITH CO., LTD. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-11-17 ✅ Patent 12,570,719 granted on 2026-03-10
US20220362298A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR COMPRISING ANTI C-MET ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF, AND USE THEREOF

#2 | 2021-12-30 ✅ Patent 12,180,287 granted on 2024-12-31
US20210403576A1
Chemistry; metallurgy

Anti-c-Met antibody showing enhanced stability or antigen-binding fragments thereof

#3 | 2021-10-14 ✅ Patent 11,975,039 granted on 2024-05-07
US20210315958A1
Human necessities

Herbal composition for treatment of attention deficit hyperactivity disorder

#4 | 2021-03-11 ✅ Patent 11,634,728 granted on 2023-04-25
US20210071199A1
Chemistry; metallurgy

Adeno-associated virus (AAV) vector having hybrid HGF gene introduced thereto

#5 | 2021-01-07 ✅ Patent 11,541,097 granted on 2023-01-03
US20210000905A1
Human necessities

Crude drug composition for preventing or treating respiratory diseases

#6 | 2020-12-31 ✅ Patent 11,559,555 granted on 2023-01-24
US20200405798A1
Human necessities

Crude drug composition for preventing or treating respiratory diseases

#7 | 2020-01-23 ✅ Patent 11,464,875 granted on 2022-10-11
US20200023077A1
Human necessities

Treatment of neuropathy with DNA constructs expressing IGF-1 isoforms

#8 | 2020-01-23 ✅ Patent 11,554,179 granted on 2023-01-17
US20200023075A1
Human necessities

Lyophilized pharmaceutical compositions for naked DNA gene therapy

#9 | 2019-10-17 ✅ Patent 10,927,177 granted on 2021-02-23
US20190315872A1
Chemistry; metallurgy

Methods of treatment using anti-c-met antibodies

#10 | 2019-08-08 ✅ Patent 10,759,841 granted on 2020-09-01
US20190241632A1
Chemistry; metallurgy

Gene therapy for diabetic neuropathy using an HGF isoform

#11 | 2019-03-21 ✅ Patent 11,279,769 granted on 2022-03-22
US20190085092A1
Chemistry; metallurgy

Anti-Sialyl Tn chimeric antigen receptors

#12 | 2017-10-05 ✅ Patent 11,219,667 granted on 2022-01-11
US20170281729A1
Human necessities

Method for treating peripheral vascular disease using hepatocyte growth factor and stromal cell derived factor 1A

#13 | 2016-09-01 ✅ Patent 10,639,351 granted on 2020-05-05
US20160250291A1
Human necessities

Method for treating amyotrophic lateral sclerosis with a polynucleotide encoding two or more isoforms of hepatocyte growth factor

Also check out Helixmith Co., Ltd.'s (Seoul, South Korea) applicant profile with 14 patent applications submitted.

AssigneeID:

316066 ⎘